PIN31 COST-EFFECTIVENESS ANALYSIS OF TELBIVUDINE VS LAMIVUDINE IN TREATING THE PATIENTS WITH HBEAG-POSITIVE AND -NEGATIVE CHRONIC HEPATITIS B IN CHINA
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75089-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)75089-0/fulltext
Title :
PIN31 COST-EFFECTIVENESS ANALYSIS OF TELBIVUDINE VS LAMIVUDINE IN TREATING THE PATIENTS WITH HBEAG-POSITIVE AND -NEGATIVE CHRONIC HEPATITIS B IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75089-0&doi=10.1016/S1098-3015(10)75089-0
First page :
Section Title :
Open access? :
No
Section Order :
1014